News

The National Board of Examinations in Medical Sciences (NBEMS) has announced the NEET MDS 2025 results on May 15. A total of 30,435 candidates registered for the exam held on April 19. Results ...
The National Board of Examinations in Medical Sciences (NBEMS) will conduct the National Eligibility cum Entrance Test (NEET)-MDS 2025 on April 19, 2025. Candidates who have registered for the ...
Designed by MDS Architecture, in association with Architects Unbound, the Mall was developed by McCormick Property Development (MPD) and Seven Days Trading Pty Ltd for Exemplar. Work on site began ...
NEET MDS 2025 correction window will open today, March 14, 2025. The steps to make changes in application form is given here. National Board of Examinations in Medical Sciences will open NEET MDS ...
In 2024, an estimated 9,280 people were diagnosed with CML 1, over 10,000 with MDS/MPD 2, and up to 6,000 with GIST 3 in the U.S. Despite the proven clinical benefits of imatinib, patient ...
Consider performing an echocardiogram and determining serum troponin in patients with HES/CEL, and in patients with MDS/MPD or ASM associated with high eosinophil levels. If either is abnormal ...
The National Board of Examinations in Medical Sciences (NBEMS) has opened registrations for the NEET MDS 2025, starting February 18. Interested candidates must apply by March 10, 2025. Eligibility ...
In MPNs, too many blood stem cells (immature cells) in the bone marrow develop into mature blood cells. These extra cells build up in the blood and bone marrow over time. This condition usually gets ...
IMKELDI can help slow or prevent the growth of specific cancers, including chronic myeloid leukemia (CML) and acute lymphoblastic leukemia, myelodysplastic syndrome /myeloproliferative disease ...
The therapy can help patients combat myelodysplastic syndrome/myeloproliferative disease (MDS/MPD), gastrointestinal tumors (GIST) and cancers such as chronic myeloid leukemia (CML) and acute ...
With over 9000 people being diagnosed with CML in 2024, more than 10,000 with MDS or MPD, nearly 6000 with GIST, and upwards of 6500 expected to be diagnosed with ALL by the end of the year ...